MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

Model Number	BEA25-70/I20-30
Medical Device Problem Code	Separation Problem (4043)
Health Effect - Clinical Codes	Aneurysm (1708); Cardiopulmonary Arrest (1765); Death (1802); Failure of Implant (1924); Rupture (2208)
Date of Event	11/15/2020
Type of Reportable Event	Death
Additional Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
Event or Problem Description
The patient was initially implanted with an afx2 bifurcated stent graft, a vela suprarenal stent graft, a vela infrarenal stent graft, a non-endologix excluder device, a non-endologix gore proximal extension and a non-endologix bare stent graft to treat an abdominal aortic aneurysm (aaa).This procedure is outside the indications of use due to concomitant use with products outside the ifu.Approximately six (6) to twelve (12) months post initial procedure, aneurysm enlargement was identified and a possible endoleak was suspected.However no additional intervention was performed.Now approximately one (1) year later, a type 3a endoleak was identified.An intervention was planned, however, the patient presented emergently to the hospital with an aneurysm rupture and cardiac arrest.The physician performed a reintervention, and implanted a non-endologix endurant proximal extension during this event.The patient's condition continued to decline and the patient expired.
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type 3a (aortic) endoleak, rupture, and cardiac arrest are unconfirmed due to a lack of the relevant medical information.This is not consistent with the reported adverse event/incident.Procedure-related harms, device, user, procedure, or anatomy relatedness of this complaint could not be determined with the medical records available for review.The final patient status was reported as expired post the secondary endovascular procedure.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.

• Brand Name: AFX2
• Common Device Name: BIFURCATED STENT GRAFT
• Manufacturer (Section D): ENDOLOGIX; 2 musick; irvine CA 92618
• MDR Report Key: 10977418
• Report Number: 2031527-2020-00364
• Device Sequence Number: 19030390
• Product Code: MIH
• UDI-Device Identifier: 00818009014832
• UDI-Public: (01)00818009014832(17)181027
• Combination Product (Y/N): N
• Initial Reporter Country: JA
• PMA/510(K) Number: P040002
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Reporter Type: Manufacturer
• Report Source: distributor,foreign,other
• Initial Reporter Occupation: Physician
• Remedial Action: Other,Recall
• Type of Report: Initial,Followup
• Report Date (Section B): 11/19/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 10/27/2018
• Device Model Number: BEA25-70/I20-30
• Device Lot Number: 1753455003
• Was Device Available for Evaluation?: No
• Initial Date Received by Manufacturer: 11/19/2020
• Supplement Date Received by Manufacturer: 01/29/2021
• Initial Report FDA Received Date: 12/09/2020
• Supplement Report FDA Received Date: 02/10/2021
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: Z-0007-2019
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: NON-ENDOLOGIX BARE STENT; NON-ENDOLOGIX EXCLUDER; NON-ENDOLOGIX GORE PROXIMAL EXTENSION; VELA INFRARENAL ENDOGRAFT, LOT# 1761204005; VELA SUPRARENAL ENDOGRAFT, LOT# 1769441013; NON-ENDOLOGIX BARE STENT; NON-ENDOLOGIX EXCLUDER; NON-ENDOLOGIX GORE PROXIMAL EXTENSION; VELA INFRARENAL ENDOGRAFT, LOT# 1761204005; VELA SUPRARENAL ENDOGRAFT, LOT# 1769441013
• Outcome Attributed to Adverse Event: Death
• Patient Age: 89 YR